Price Alert

Achieve Life Sciences Inc... (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

2.83

0.04 (1.43%)

At close: Sep 05, 2025, 3:59 PM

2.85

0.53%

After-hours: Sep 05, 2025, 07:37 PM EDT

1.43% (1D)

Bid	2.73
Market Cap	144.63M
Revenue (ttm)	228K
Net Income (ttm)	-50.42M
EPS (ttm)	-1.48
PE Ratio (ttm)	-1.91
Forward PE	-2.7
Analyst	Strong Buy

Ask	2.87
Volume	1,380,144
Avg. Volume (20D)	1,253,382
Open	2.81
Previous Close	2.79
Day's Range	2.68 - 2.87
52-Week Range	1.84 - 5.31
Beta	1.31

About ACHV

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACHV

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

+12.02%

Achieve Life Sciences shares are trading higher af... Unlock content with Pro Subscription

2 months ago

-36.47%

Achieve Life Sciences shares are trading lower after the company announced a $45 million public offering.

News

2 weeks ago · benzinga.com

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences Inc. ACHV is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the ...

4 weeks ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Cindy Jacobs - Former President & Chief Medical Officer Jaime Xinos - Chief Commercial O...

4 weeks ago · fool.com

Achieve (ACHV) Q2 Net Loss Hits $12.7M

2 months ago · seekingalpha.com

Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation

ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation, supported by strong clinical data and recent NDA submission. The target market is large, with millions seeking smoki...

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV)

Squarepoint Ops LLC bought a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing...